Hemogenyx Pharmaceuticals PLC (HEMO) — Capital Reinvestment Ratio

Latest as of June 2017: 0.47x

Hemogenyx Pharmaceuticals PLC (HEMO) has a Capital Reinvestment Ratio of 0.47x as of June 2017, meaning it reinvests 0% of its operating cash flow (GBX23.26) in capital expenditures (GBX11.02). See HEMO cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.47x

Capex / Operating Cash Flow

Operating Cash Flow

GBX23.26

GBX

Capital Expenditures

GBX11.02

GBX

Data as of

Jun 2017

Most recent filing

Annual Capital Reinvestment Ratio for Hemogenyx Pharmaceuticals PLC (None–None)

Year-by-year Capital Reinvestment Ratio for Hemogenyx Pharmaceuticals PLC from None to None. For live market cap and broader valuation context, see HEMO stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (GBX)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow